[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
BioMed Central
- To: "'liblicense-l@lists.yale.edu'" <liblicense-l@lists.yale.edu>
- Subject: BioMed Central
- From: Gordon Fletcher <Gordon@biomedcentral.com>
- Date: Wed, 18 Jul 2001 17:11:33 EDT
- Reply-To: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
Dear Phil Thanks for your interest in BioMed Central. I hope this email can clear up any confusion surrounding the different companies, services and products you mentioned. 1. BioMedNet is a web service owned and operated by Elsevier Science. 2. PubMed Central is not a journal publisher but a US government supported service. They describe themselves as "a digital archive of life sciences journal literature managed by the National Center for Biotechnology Information at the U.S. National Library of Medicine". Access to PubMed Central is free and unrestricted. 3. BioMed Central is a limited company, independent of government or society funding or subsidies. The confusion with regard to these names is unfortunate, but we hope increasing familiarity with the products, services and companies will no-doubt alleviate this situation, just as there is little confusion nowadays as to the difference between the journals Science, The Scientist, New Scientist, and The Sciences. BioMed Central Ltd is part of the Current Science Group and is a business hoping eventually to make a fair profit by offering a service to the scientific community that is second to none. There is no particular desire or intention to hide or withhold this information. It is clearly mentioned on our website, in the "Who we are" section. BioMed Central has, admittedly, an unusual business model, with free access to primary research publications as one of its most notable policies. We intend to demonstrate that this is a viable model, which if adopted widely, may reduce the total cost of published research information to the scientific community by as much as a factor of 10 and materially increase its availability at the same time. Useful Links: BioMed Central - who we are (http://www.biomedcentral.com/info/whoweare.asp) Current Science Group (http://www.currentsciencegroup.com) PubMed Central (http://www.pubmedcentral.nih.gov/) BioMedNet (http://www.bmn.com) Regards Dr Gordon Fletcher Press Officer BioMed Central Limited Middlesex House 32-34 Cleveland Street London W1T 4LB Tel: +44 (0)20 7323 0323 ext 2331 E-mail: gordon@biomedcentral.com Web: www.biomedcentral.com
- Prev by Date: Re: BioMed Cetral press release
- Next by Date: RE: The Charleston Advisor-latest issue
- Prev by thread: RE: WHO Biomed Journals Initiative, more
- Next by thread: Soros Seeks to Provide Quality Journals for Developing Countries
- Index(es):